Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
-
Sheng-kai Yan
Abstract
Background: Studies that considered polymorphisms within the apolipoprotein B (APOB) gene as risk factors for coronary heart disease (CHD) have reported conflicting results.
Methods: The phenotypic effects of the 3′VNTR polymorphism of the APOB gene on the susceptibility to CHD were investigated in 120 unrelated healthy individuals and 137 CHD patients. The internal structure of APOB gene 3′VNTR alleles was also analyzed by the methods of SspI restriction mapping and DNA sequencing of the allele fragments.
Results: In total, 14 segregating alleles and 32 genotypes of APOB gene 3′VNTR were characterized in the pooled total of 257 subjects. The frequency of 3′VNTR-B alleles [hypervariable element (HVE) ≥38)] in the CHD cases was higher than that of the controls (10.95% vs. 5.00%, p<0.05). 3′VNTR-B allele was dependently related to total cholesterol levels (p<0.05). Compared with SS homozygotes, 3′VNTR-B allele carriers were associated with an increased risk of CHD (OR=2.137, 95% CI=1.055–4.328, p=0.0349). No significant differences in the internal structure and sequences of APOB gene 3′VNTR alleles were found between cases and controls.
Conclusions:APOB gene 3′VNTR polymorphism exerts an impact on lipid metabolism and may contribute to the susceptibility to the development of CHD in Han Chinese.
Clin Chem Lab Med 2006;44:1199–205.
References
1. Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J Biol Chem 1992; 267:25621–4.10.1016/S0021-9258(18)35646-1Search in Google Scholar
2. Olofsson SO, Boren J. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J Intern Med 2005; 258:395–410.10.1111/j.1365-2796.2005.01556.xSearch in Google Scholar
3. Whitfield AJ, Barrett PH, van Bockxmeer FM, Burnett JR. Lipid disorders and mutations in the APOB gene. Clin Chem 2004; 50:1725–32.10.1373/clinchem.2004.038026Search in Google Scholar
4. Knott TJ, Wallis SC, Pease RJ, Powell LM, Scott J. A hyper-variable region 34 to the human apolipoprotein B gene. Nucleic Acids Res 1986; 14:9215–6.10.1093/nar/14.22.9215Search in Google Scholar
5. Verbenko DA, Knjazev AN, Mikulich AI, Khusnutdinova EK, Bebyakova NA, Limborska SA. Variability of the 3′ APOB minisatellite locus in Eastern Slavonic populations. Hum Hered 2005; 60:10–8.10.1159/000087338Search in Google Scholar
6. Das B, Ghosh A, Chauhan PS, Seshadri M. Genetic polymorphism study at four minisatellite loci (D1S80, D117S5, D19S20, and APOB) among five Indian population groups. Hum Biol 2002; 74:345–61.10.1353/hub.2002.0028Search in Google Scholar
7. Buresi C, Desmarais E, Vigneron S, Ben Rayana C, Chaabouni H, Roizes G. Polymorphism at VNTR locus 3 to the apolipoprotein B gene in a Tunisian population: difference from other ethnic groups. Genet Epidemiol 1995; 12:381–9.10.1002/gepi.1370120406Search in Google Scholar
8. Boerwinkle E, Xiong W, Fourest E, Lawrence C. Rapid typing of tandemly repeated hyper-variable loci by the polymerase chain reaction: application to the apolipoprotein B 3′ hyper-variable region. Proc Natl Acad Sci USA 1989; 86:212–6.10.1073/pnas.86.1.212Search in Google Scholar
9. Deka R, Chakraborty R, Decroo S, Rothhammer F, Ferrell RE. Characteristics of polymorphism at a VNTR locus 3′ to the apolipoprotein B gene in five human populations. Am J Hum Genet 1992; 51:1325–33.Search in Google Scholar
10. Ludwig EH, Freidl W, McCarthy BJ. High-resolution analysis of a hypervariable region in the human apolipoprotein B gene. Am J Human Genet 1989; 45:458–64.Search in Google Scholar
11. Helio T. Concept of VNTR alleles: comparison of apolipoprotein B 3′ hypervariable region genotyping results obtained by three methods. Biochem Biophys Res Commun 1991; 181:846–51.10.1016/0006-291X(91)91267-GSearch in Google Scholar
12. Alavantić D, Glišić S, Kandić I. APO B 3′ HVR polymorphism in healthy populations: relationships to serum lipid levels. Genet Epidemiol 1998; 15:113–22.10.1002/(SICI)1098-2272(1998)15:2<113::AID-GEPI1>3.0.CO;2-7Search in Google Scholar
13. Ye P, Chen B, Wang S. Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Han Chinese. Atherosclerosis 1995; 117:43–50.10.1016/0021-9150(95)05556-CSearch in Google Scholar
14. Hegele RA, Huang LS, Herbert PN, Blum CB, Buring JE, Hennekens CH, et al. Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. N Engl J Med 1986; 315:1509–15.10.1056/NEJM198612113152403Search in Google Scholar
15. Pan JP. Chiang AN, Chou CY, Chan WL, Tai JJ. Polymorphisms of the apolipoprotein B 3′ variable number of tandem repeats region associated with coronary artery disease in Taiwanese. J Formos Med Assoc 1998; 97:233–8.Search in Google Scholar
16. Renges HH, Peacock R, Dunning AM, Talmud P, Humphries SE. Genetic relationship between the 3′-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin. Ann Hum Genet 1992; 56:11–33.10.1111/j.1469-1809.1992.tb01126.xSearch in Google Scholar
17. Helio T, Palotie A, Totterman KJ, Ott J, Kauppinen-Makelin R, Tikkanen MJ. Lack of association between the apolipoprotein B gene 3′ hypervariable region alleles and coronary artery disease in Finnish patients with angiographically documented coronary artery disease. J Intern Med 1992; 231:49–57.10.1111/j.1365-2796.1992.tb00498.xSearch in Google Scholar
18. Buresi C, Desmarais E, Vigneron S, Lamarti H, Smaoui N, Cambien F, et al. Structural analysis of the minisatellite present at the 3′ end of the human apolipoprotein B gene: new definition of the alleles and evolutionary implications. Hum Mol Genet 1996; 5:61–8.10.1093/hmg/5.1.61Search in Google Scholar
19. Yan S, Zhou X, Lin Q, Song Y. Association of polymorphism of apolipoprotein E gene with coronary heart disease in Han Chinese. Chin Med J 1999; 112:224–7.Search in Google Scholar
20. Chen B, Guo Z, He P, Buresi C, Roizes G. Structure and function of alleles in the 3′ end region of human apoB gene. Chin Med J 1999; 112:221–3.Search in Google Scholar
21. Chen B, Guo Z, He P, Lu X, Bai G, Jin J. The distribution and sequencing of ApoB gene 3′-variable number of tandemly repeat alleles in Chinese Han and Mongolian nationalities. Chin J Arterioscler 1996; 4:93–9.Search in Google Scholar
22. Chen B, Zhao Y, Cheng Y. Polymorphisms of apoB gene 3′ VNTR alleles and analysis of lipid level in Tibetan population. Natl Med J China 1999; 79:505–8.Search in Google Scholar
23. Verbenko DA, Pogoda TV, Spitsyn VA, Mikulich AI, Bets LV, Bebyakova NA, et al. Apolipoprotein B 3′-VNTR polymorphism in Eastern European populations. Eur J Hum Genet 2003; 11:444–51.10.1038/sj.ejhg.5200986Search in Google Scholar
24. Desmarais E, Vigneron S, Buresi C, Cambien F, Cambou JP, Roizes G. Variant mapping of the Apo (B) rich minisatellite. Dependence on nucleotide sequence of the copy number variations. Instability of the non-canonical alleles. Nucleic Acids Res 1993; 21:2179–84.10.1093/nar/21.9.2179Search in Google Scholar
25. Alavantić D, Glišić S, Erceg S, Stupar M. Genetic variation at the apoB 3′ hypervariable region in a Serbian population. Eur J Hum Genet 1997; 5:333–5.10.1159/000484785Search in Google Scholar
26. Friedl W, Ludwig EH, Paulweber B, Sandhofer F, McCarthy BJ. Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal control. J Lipid Res 1990; 31:659–65.10.1016/S0022-2275(20)42834-2Search in Google Scholar
27. Wu JH, Chern MS, Lo SK, Wen MS, Kao JT. Apolipoprotein B 3′ hypervariable repeat genotype: association with plasma lipid concentration, coronary artery disease, and other restriction fragment polymorphisms. Clin Chem 1996; 42:927–32.10.1093/clinchem/42.6.927Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
Articles in the same Issue
- Multiplexed testing in the autoimmunity laboratory
- Uncertainty calculation for calibrators and controls of laboratory diagnostic assays
- Westgard multirule for calculated laboratory tests
- Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations
- The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function
- Apolipoprotein B gene 3′VNTR polymorphism: association with plasma lipids and coronary heart disease in Han Chinese
- Paraoxonase-1 (PON1) activity, but not PON1Q192R phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population
- A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy
- Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis
- Lipid peroxidation and antioxidative status in β-thalassemia major patients with or without hepatitis C virus infection
- Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males
- Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum
- Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism
- Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support
- Biovariability of plasma adiponectin
- Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood
- Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison
- Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing
- The importance of metrological traceability on the validity of creatinine measurement as an index of renal function: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
- Effect of seropositive rheumatoid factor on cardiac troponin I measurement using the Access® Immunoassay Analyzer
